Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 330

1.

Positron-emission tomography-based staging reduces the prognostic impact of early disease progression in patients with follicular lymphoma.

Batlevi CL, Sha F, Alperovich A, Ni A, Smith K, Ying Z, Gerecitano JF, Hamlin PA, Horwitz SM, Joffe E, Kumar A, Matasar MJ, Moskowitz AJ, Moskowitz CH, Noy A, Owens C, Palomba LM, Straus D, von Keudell G, Zelenetz AD, Seshan VE, Luminari S, Marcheselli L, Federico M, Younes A.

Eur J Cancer. 2020 Jan 8;126:78-90. doi: 10.1016/j.ejca.2019.12.006. [Epub ahead of print]

PMID:
31927165
2.

Evaluation of a Web-Based Training Model for Family Peer Advocates in Children's Mental Health.

Horwitz SM, Cervantes P, Kuppinger AD, Quintero PL, Burger S, Lane H, Bradbury D, Cleek AF, Hoagwood KE.

Psychiatr Serv. 2020 Jan 8:appips201900365. doi: 10.1176/appi.ps.201900365. [Epub ahead of print]

PMID:
31910753
3.

Incidence and outcomes of rare T cell lymphomas from the T Cell Project: hepatosplenic, enteropathy associated and peripheral gamma delta T cell lymphomas.

Foss FM, Horwitz SM, Civallero M, Bellei M, Marcheselli L, Kim WS, Cabrera ME, Dlouhy I, Nagler A, Advani RH, Pesce EA, Ko YH, Montoto S, Chiattone C, Moskowitz A, Spina M, Cesaretti M, Biasoli I, Federico M.

Am J Hematol. 2020 Feb;95(2):151-155. doi: 10.1002/ajh.25674. Epub 2019 Nov 25.

PMID:
31709579
4.

TFH lymphomas: the times they aza-changin'?

Weinstock DM, Horwitz SM.

Blood. 2019 Oct 24;134(17):1364-1365. doi: 10.1182/blood.2019002806. No abstract available.

5.

Clinical, cortical thickness and neural activity predictors of future affective lability in youth at risk for bipolar disorder: initial discovery and independent sample replication.

Bertocci MA, Hanford L, Manelis A, Iyengar S, Youngstrom EA, Gill MK, Monk K, Versace A, Bonar L, Bebko G, Ladouceur CD, Perlman SB, Diler R, Horwitz SM, Arnold LE, Hafeman D, Travis MJ, Kowatch R, Holland SK, Fristad MA, Findling RL, Birmaher B, Phillips ML.

Mol Psychiatry. 2019 Dec;24(12):1856-1867. doi: 10.1038/s41380-018-0273-4. Epub 2018 Oct 19.

6.

Incidence of benign and malignant peri-implant fluid collections and masses on magnetic resonance imaging in women with silicone implants.

Sutton EJ, Dashevsky BZ, Watson EJ, Tyagi N, Bernard-Davila B, Martinez D, Dogan A, Horwitz SM, Cordeiro PG, Morris EA.

Cancer Med. 2019 Sep 30. doi: 10.1002/cam4.2189. [Epub ahead of print]

7.

Pembrolizumab in Relapsed and Refractory Mycosis Fungoides and Sézary Syndrome: A Multicenter Phase II Study.

Khodadoust MS, Rook AH, Porcu P, Foss F, Moskowitz AJ, Shustov A, Shanbhag S, Sokol L, Fling SP, Ramchurren N, Pierce R, Davis A, Shine R, Li S, Fong S, Kim J, Yang Y, Blumenschein WM, Yearley JH, Das B, Patidar R, Datta V, Cantu E, McCutcheon JN, Karlovich C, Williams PM, Subrahmanyam PB, Maecker HT, Horwitz SM, Sharon E, Kohrt HE, Cheever MA, Kim YH.

J Clin Oncol. 2020 Jan 1;38(1):20-28. doi: 10.1200/JCO.19.01056. Epub 2019 Sep 18.

PMID:
31532724
8.

Outcomes and Prognostic Factors In African American / Black Patients With Mycosis Fungoides And Sézary Syndrome: Retrospective Analysis Of 157 Patients From A Referral Cancer Center.

Geller S, Lebowitz E, Pulitzer MP, Horwitz SM, Moskowitz AJ, Dusza S, Myskowski PL.

J Am Acad Dermatol. 2019 Sep 6. pii: S0190-9622(19)32681-7. doi: 10.1016/j.jaad.2019.08.073. [Epub ahead of print]

PMID:
31499157
9.

Level of evidence used in recommendations by the National Comprehensive Cancer Network (NCCN) guidelines beyond Food and Drug Administration approvals.

Kurzrock R, Gurski LA, Carlson RW, Ettinger DS, Horwitz SM, Kumar SK, Million L, von Mehren M, Benson AB.

Ann Oncol. 2019 Oct 1;30(10):1647-1652. doi: 10.1093/annonc/mdz232.

10.

C-C chemokine receptor 4 expression in CD8+ cutaneous T-cell lymphomas and lymphoproliferative disorders, and its implications for diagnosis and treatment.

Geller S, Hollmann TJ, Horwitz SM, Myskowski PL, Pulitzer M.

Histopathology. 2020 Jan;76(2):222-232. doi: 10.1111/his.13960. Epub 2019 Nov 13.

PMID:
31355940
11.

Outcomes for Relapsed and Refractory Peripheral T-Cell Lymphoma Patients after Front-Line Therapy from the COMPLETE Registry.

Lansigan F, Horwitz SM, Pinter-Brown LC, Rosen ST, Pro B, Hsi ED, Federico M, Gisselbrecht C, Schwartz M, Bellm LA, Acosta M, Shustov AR, Advani RH, Feldman T, Lechowicz MJ, Smith SM, Tulpule A, Craig MD, Greer JP, Kahl BS, Leach JW, Morganstein N, Casulo C, Park SI, Foss FM.

Acta Haematol. 2020;143(1):40-50. doi: 10.1159/000500666. Epub 2019 Jul 17.

PMID:
31315113
12.

Impact of a Trauma-Informed Intervention for Youth and Staff on Rates of Violence in Juvenile Detention Settings.

Baetz CL, Surko M, Moaveni M, McNair F, Bart A, Workman S, Tedeschi F, Havens J, Guo F, Quinlan C, Horwitz SM.

J Interpers Violence. 2019 Jun 28:886260519857163. doi: 10.1177/0886260519857163. [Epub ahead of print]

PMID:
31253054
13.

Multicenter analysis of outcomes in blastic plasmacytoid dendritic cell neoplasm offers a pretargeted therapy benchmark.

Taylor J, Haddadin M, Upadhyay VA, Grussie E, Mehta-Shah N, Brunner AM, Louissaint A Jr, Lovitch SB, Dogan A, Fathi AT, Stone RM, Tallman MS, Rampal RK, Neuberg DS, Stevenson KE, Horwitz SM, Lane AA.

Blood. 2019 Aug 22;134(8):678-687. doi: 10.1182/blood.2019001144. Epub 2019 Jun 26.

PMID:
31243042
14.

Patterns of survival in patients with recurrent mantle cell lymphoma in the modern era: progressive shortening in response duration and survival after each relapse.

Kumar A, Sha F, Toure A, Dogan A, Ni A, Batlevi CL, Palomba MLM, Portlock C, Straus DJ, Noy A, Horwitz SM, Moskowitz A, Hamlin P, Moskowitz CH, Matasar MJ, Zelenetz AD, Younes A.

Blood Cancer J. 2019 May 20;9(6):50. doi: 10.1038/s41408-019-0209-5.

15.

Targeting CD47 in Sézary syndrome with SIRPαFc.

Johnson LDS, Banerjee S, Kruglov O, Viller NN, Horwitz SM, Lesokhin A, Zain J, Querfeld C, Chen R, Okada C, Sawas A, O'Connor OA, Sievers EL, Shou Y, Uger RA, Wong M, Akilov OE.

Blood Adv. 2019 Apr 9;3(7):1145-1153. doi: 10.1182/bloodadvances.2018030577.

16.

Catalyst-free assembly of giant tris(heteroaryl)methanes: synthesis of novel pharmacophoric triads and model sterically crowded tris(heteroaryl/aryl)methyl cation salts.

Abonia R, Gutiérrez LF, Insuasty B, Quiroga J, Laali KK, Zhao C, Borosky GL, Horwitz SM, Bunge SD.

Beilstein J Org Chem. 2019 Mar 12;15:642-654. doi: 10.3762/bjoc.15.60. eCollection 2019.

17.

Post-traumatic stress and related symptoms among juvenile detention residents: Results from intake screening.

McNair FD, Havens J, Surko M, Weinberger E, Baetz C, Moaveni M, Bart A, Marr M, Quinlan C, Horwitz SM.

Child Abuse Negl. 2019 Jun;92:22-31. doi: 10.1016/j.chiabu.2019.03.011. Epub 2019 Mar 20.

PMID:
30903924
18.

Single agents vs combination chemotherapy in relapsed and refractory peripheral T-cell lymphoma: Results from the comprehensive oncology measures for peripheral T-cell lymphoma treatment (COMPLETE) registry.

Stuver RN, Khan N, Schwartz M, Acosta M, Federico M, Gisselbrecht C, Horwitz SM, Lansigan F, Pinter-Brown LC, Pro B, Shustov AR, Foss FM, Jain S.

Am J Hematol. 2019 Jun;94(6):641-649. doi: 10.1002/ajh.25463. Epub 2019 Apr 9.

PMID:
30896890
19.

Screening for and preventing perinatal depression.

Kerker BD, Greene JA, Gerson R, Pollock M, Hoagwood KE, Horwitz SM.

J Child Fam Stud. 2018 Oct;27(10):3169-3175. doi: 10.1007/s10826-018-1157-6. Epub 2018 Jun 20.

20.

A new target in CTCL: treating the skin, blood, and lymph nodes.

Horwitz SM.

Clin Adv Hematol Oncol. 2019 Jan;17(1):40-43. No abstract available.

PMID:
30843897
21.

Active surveillance for nodular lymphocyte-predominant Hodgkin lymphoma.

Borchmann S, Joffe E, Moskowitz CH, Zelenetz AD, Noy A, Portlock CS, Gerecitano JF, Batlevi CL, Caron PC, Drullinsky P, Hamilton A, Hamlin PA Jr, Horwitz SM, Kumar A, Matasar MJ, Moskowitz AJ, Owens CN, Palomba ML, Younes A, Straus DJ.

Blood. 2019 May 16;133(20):2121-2129. doi: 10.1182/blood-2018-10-877761. Epub 2019 Feb 15.

PMID:
30770396
22.

Mycosis fungoides, Psoriasis und PD-1-Inhibitoren - neuer Aspekt einer bekannten Assoziation.

Geller S, Pulitzer M, Horwitz SM, Moskowitz AJ, Myskowski PL.

J Dtsch Dermatol Ges. 2019 Feb;17(2):186-188. doi: 10.1111/ddg.13715_g. No abstract available.

PMID:
30762967
23.

Sustainability of an Evidence-Based Practice in Community Mental Health Agencies Serving Children.

Horwitz SM, Lewis K, Gleacher A, Wang N, Bradbury DM, Ray-LaBatt M, Hoagwood KE.

Psychiatr Serv. 2019 May 1;70(5):413-416. doi: 10.1176/appi.ps.201800430. Epub 2019 Feb 13.

PMID:
30755132
24.

2019 NCCN Consensus Guidelines on the Diagnosis and Treatment of Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL).

Clemens MW, Jacobsen ED, Horwitz SM.

Aesthet Surg J. 2019 Jan 31;39(Supplement_1):S3-S13. doi: 10.1093/asj/sjy331.

PMID:
30715173
25.

Randomized Phase III Study of Alisertib or Investigator's Choice (Selected Single Agent) in Patients With Relapsed or Refractory Peripheral T-Cell Lymphoma.

O'Connor OA, Özcan M, Jacobsen ED, Roncero JM, Trotman J, Demeter J, Masszi T, Pereira J, Ramchandren R, Beaven A, Caballero D, Horwitz SM, Lennard A, Turgut M, Hamerschlak N, d'Amore FA, Foss F, Kim WS, Leonard JP, Zinzani PL, Chiattone CS, Hsi ED, Trümper L, Liu H, Sheldon-Waniga E, Ullmann CD, Venkatakrishnan K, Leonard EJ, Shustov AR; Lumiere Study Investigators.

J Clin Oncol. 2019 Mar 10;37(8):613-623. doi: 10.1200/JCO.18.00899. Epub 2019 Feb 1.

PMID:
30707661
26.

Role of imaging in low-grade cutaneous B-cell lymphoma presenting in the skin.

Kheterpal MK, Dai J, Geller S, Pulitzer M, Ni A, Myskowski PL, Moskowitz A, Kim J, Hong EK, Fong S, Hoppe RT, Kim YH, Horwitz SM.

J Am Acad Dermatol. 2019 Oct;81(4):970-976. doi: 10.1016/j.jaad.2019.01.037. Epub 2019 Jan 29.

PMID:
30703460
27.

The role of autologous stem cell transplantation in patients with nodal peripheral T-cell lymphomas in first complete remission: Report from COMPLETE, a prospective, multicenter cohort study.

Park SI, Horwitz SM, Foss FM, Pinter-Brown LC, Carson KR, Rosen ST, Pro B, Hsi ED, Federico M, Gisselbrecht C, Schwartz M, Bellm LA, Acosta M, Advani RH, Feldman T, Lechowicz MJ, Smith SM, Lansigan F, Tulpule A, Craig MD, Greer JP, Kahl BS, Leach JW, Morganstein N, Casulo C, Shustov AR; COMPLETE Investigators.

Cancer. 2019 May 1;125(9):1507-1517. doi: 10.1002/cncr.31861. Epub 2019 Jan 29. Erratum in: Cancer. 2019 Nov 1;125(21):3893.

PMID:
30694529
28.

Baseline and interim functional imaging with PET effectively risk stratifies patients with peripheral T-cell lymphoma.

Mehta-Shah N, Ito K, Bantilan K, Moskowitz AJ, Sauter C, Horwitz SM, Schöder H.

Blood Adv. 2019 Jan 22;3(2):187-197. doi: 10.1182/bloodadvances.2018024075.

29.

Angioimmunoblastic T-Cell Lymphoma.

Yabe M, Dogan A, Horwitz SM, Moskowitz AJ.

Cancer Treat Res. 2019;176:99-126. doi: 10.1007/978-3-319-99716-2_5.

PMID:
30596215
30.

Mogamulizumab versus investigator's choice of chemotherapy regimen in relapsed/refractory adult T-cell leukemia/lymphoma.

Phillips AA, Fields PA, Hermine O, Ramos JC, Beltran BE, Pereira J, Wandroo F, Feldman T, Taylor GP, Sawas A, Humphrey J, Kurman M, Moriya J, Dwyer K, Leoni M, Conlon K, Cook L, Gonsky J, Horwitz SM; 0761-009 Study Group.

Haematologica. 2019 May;104(5):993-1003. doi: 10.3324/haematol.2018.205096. Epub 2018 Dec 20.

31.

Mycosis fungoides, Psoriasis and Anti-PD-1 - A New Aspect of Known Associations.

Geller S, Pulitzer M, Horwitz SM, Moskowitz AJ, Myskowski PL.

J Dtsch Dermatol Ges. 2019 Feb;17(2):186-188. doi: 10.1111/ddg.13715. Epub 2018 Dec 14. No abstract available.

PMID:
30549439
32.

Cutaneous T-cell lymphoma (CTCL), rare subtypes: five case presentations and review of the literature.

Geller S, Myskowski PL, Pulitzer M, Horwitz SM, Moskowitz AJ.

Chin Clin Oncol. 2019 Feb;8(1):5. doi: 10.21037/cco.2018.11.01. Epub 2018 Nov 21. Review.

33.

Breast implant-associated anaplastic large cell lymphoma: Clinical and imaging findings at a large US cancer center.

Dashevsky BZ, Gallagher KM, Grabenstetter A, Cordeiro PG, Dogan A, Morris EA, Horwitz SM, Sutton EJ.

Breast J. 2019 Jan;25(1):69-74. doi: 10.1111/tbj.13161. Epub 2018 Dec 6.

PMID:
30521149
34.

Associations between Parental Psychopathology and Sexual Behavior in an Outpatient Psychiatric Sample.

Black SR, Seager I, Meers MR, Arnold LE, Birmaher B, Findling RL, Horwitz SM, Youngstrom EA, Fristad MA.

J Clin Child Adolesc Psychol. 2020 Jan-Feb;49(1):50-59. doi: 10.1080/15374416.2018.1514614. Epub 2018 Oct 30.

PMID:
30376641
35.

Novel Immunotherapies for T Cell Lymphoma and Leukemia.

Ghione P, Moskowitz AJ, De Paola NEK, Horwitz SM, Ruella M.

Curr Hematol Malig Rep. 2018 Dec;13(6):494-506. doi: 10.1007/s11899-018-0480-8. Review.

36.

Correlates of Perinatal Post-Traumatic Stress among Culturally Diverse Women with Depressive Symptomatology.

Vignato J, Connelly CD, Bush RA, Georges JM, Semino-Asaro S, Calero P, Horwitz SM.

Issues Ment Health Nurs. 2018 Oct;39(10):840-849. doi: 10.1080/01612840.2018.1488313. Epub 2018 Oct 2.

37.

Treatment of Rosai-Dorfman disease with oral bexarotene: a case series.

Geller S, Busam K, Hamlin PA, Moskowitz AJ, Horwitz SM, Myskowski PL.

J Dermatolog Treat. 2019 Aug;30(5):503-505. doi: 10.1080/09546634.2018.1528001. Epub 2018 Nov 19.

PMID:
30244619
38.

How I treat breast implant-associated anaplastic large cell lymphoma.

Mehta-Shah N, Clemens MW, Horwitz SM.

Blood. 2018 Nov 1;132(18):1889-1898. doi: 10.1182/blood-2018-03-785972. Epub 2018 Sep 12.

39.

Mogamulizumab versus vorinostat in previously treated cutaneous T-cell lymphoma (MAVORIC): an international, open-label, randomised, controlled phase 3 trial.

Kim YH, Bagot M, Pinter-Brown L, Rook AH, Porcu P, Horwitz SM, Whittaker S, Tokura Y, Vermeer M, Zinzani PL, Sokol L, Morris S, Kim EJ, Ortiz-Romero PL, Eradat H, Scarisbrick J, Tsianakas A, Elmets C, Dalle S, Fisher DC, Halwani A, Poligone B, Greer J, Fierro MT, Khot A, Moskowitz AJ, Musiek A, Shustov A, Pro B, Geskin LJ, Dwyer K, Moriya J, Leoni M, Humphrey JS, Hudgens S, Grebennik DO, Tobinai K, Duvic M; MAVORIC Investigators.

Lancet Oncol. 2018 Sep;19(9):1192-1204. doi: 10.1016/S1470-2045(18)30379-6. Epub 2018 Aug 9. Erratum in: Lancet Oncol. 2018 Nov;19(11):e581.

40.

Duvelisib, an oral dual PI3K-δ,γ inhibitor, shows clinical and pharmacodynamic activity in chronic lymphocytic leukemia and small lymphocytic lymphoma in a phase 1 study.

O'Brien S, Patel M, Kahl BS, Horwitz SM, Foss FM, Porcu P, Jones J, Burger J, Jain N, Allen K, Faia K, Douglas M, Stern HM, Sweeney J, Kelly P, Kelly V, Flinn I.

Am J Hematol. 2018 Nov;93(11):1318-1326. doi: 10.1002/ajh.25243. Epub 2018 Oct 20.

41.

Do Subspecialists Ask About and Refer Families with Psychosocial Concerns? A Comparison with General Pediatricians.

Green C, Stein REK, Storfer-Isser A, Garner AS, Kerker BD, Szilagyi M, Hoagwood KE, Horwitz SM.

Matern Child Health J. 2019 Jan;23(1):61-71. doi: 10.1007/s10995-018-2594-y.

PMID:
30030742
42.

Integrated DNA/RNA targeted genomic profiling of diffuse large B-cell lymphoma using a clinical assay.

Intlekofer AM, Joffe E, Batlevi CL, Hilden P, He J, Seshan VE, Zelenetz AD, Palomba ML, Moskowitz CH, Portlock C, Straus DJ, Noy A, Horwitz SM, Gerecitano JF, Moskowitz A, Hamlin P, Matasar MJ, Kumar A, van den Brink MR, Knapp KM, Pichardo JD, Nahas MK, Trabucco SE, Mughal T, Copeland AR, Papaemmanuil E, Moarii M, Levine RL, Dogan A, Miller VA, Younes A.

Blood Cancer J. 2018 Jun 12;8(6):60. doi: 10.1038/s41408-018-0089-0.

43.

Decreased functional connectivity in the fronto-parietal network in children with mood disorders compared to children with dyslexia during rest: An fMRI study.

Horowitz-Kraus T, Woodburn M, Rajagopal A, Versace AL, Kowatch RA, Bertocci MA, Bebko G, Almeida JRC, Perlman SB, Travis MJ, Gill MK, Bonar L, Schirda C, Diwadkar VA, Sunshine JL, Birmaher B, Axelson D, Gerry Taylor H, Horwitz SM, Frazier T, Eugene Arnold L, Fristad MA, Youngstrom EA, Findling RL, Phillips ML, Holland SK.

Neuroimage Clin. 2018 Mar 1;18:582-590. doi: 10.1016/j.nicl.2018.02.034. eCollection 2018.

44.

Diffusion imaging markers of bipolar versus general psychopathology risk in youth at-risk.

Versace A, Ladouceur CD, Graur S, Acuff HE, Bonar LK, Monk K, McCaffrey A, Yendiki A, Leemans A, Travis MJ, Diwadkar VA, Holland SK, Sunshine JL, Kowatch RA, Horwitz SM, Frazier TW, Arnold LE, Fristad MA, Youngstrom EA, Findling RL, Goldstein BI, Goldstein T, Axelson D, Birmaher B, Phillips ML.

Neuropsychopharmacology. 2018 Oct;43(11):2212-2220. doi: 10.1038/s41386-018-0083-z. Epub 2018 May 4.

45.

Targetable vulnerabilities in T- and NK-cell lymphomas identified through preclinical models.

Ng SY, Yoshida N, Christie AL, Ghandi M, Dharia NV, Dempster J, Murakami M, Shigemori K, Morrow SN, Van Scoyk A, Cordero NA, Stevenson KE, Puligandla M, Haas B, Lo C, Meyers R, Gao G, Cherniack A, Louissaint A Jr, Nardi V, Thorner AR, Long H, Qiu X, Morgan EA, Dorfman DM, Fiore D, Jang J, Epstein AL, Dogan A, Zhang Y, Horwitz SM, Jacobsen ED, Santiago S, Ren JG, Guerlavais V, Annis DA, Aivado M, Saleh MN, Mehta A, Tsherniak A, Root D, Vazquez F, Hahn WC, Inghirami G, Aster JC, Weinstock DM, Koch R.

Nat Commun. 2018 May 22;9(1):2024. doi: 10.1038/s41467-018-04356-9.

46.

Treatment of Vulvar Mycosis Fungoides Tumors With Localized Radiotherapy.

Geller S, Pitter K, Moskowitz A, Horwitz SM, Yahalom J, Myskowski PL.

Clin Lymphoma Myeloma Leuk. 2018 Jul;18(7):e279-e281. doi: 10.1016/j.clml.2018.04.010. Epub 2018 May 4. No abstract available.

47.

Pilot trial of ibrutinib in patients with relapsed or refractory T-cell lymphoma.

Kumar A, Vardhana S, Moskowitz AJ, Porcu P, Dogan A, Dubovsky JA, Matasar MJ, Zhang Z, Younes A, Horwitz SM.

Blood Adv. 2018 Apr 24;2(8):871-876. doi: 10.1182/bloodadvances.2017011916.

48.

The outcome of peripheral T-cell lymphoma patients failing first-line therapy: a report from the prospective, International T-Cell Project.

Bellei M, Foss FM, Shustov AR, Horwitz SM, Marcheselli L, Kim WS, Cabrera ME, Dlouhy I, Nagler A, Advani RH, Pesce EA, Ko YH, Martinez V, Montoto S, Chiattone C, Moskowitz A, Spina M, Biasoli I, Manni M, Federico M; International T-cell Project Network.

Haematologica. 2018 Jul;103(7):1191-1197. doi: 10.3324/haematol.2017.186577. Epub 2018 Mar 29.

49.

Five-year outcomes for frontline brentuximab vedotin with CHP for CD30-expressing peripheral T-cell lymphomas.

Fanale MA, Horwitz SM, Forero-Torres A, Bartlett NL, Advani RH, Pro B, Chen RW, Davies A, Illidge T, Uttarwar M, Lee SY, Ren H, Kennedy DA, Shustov AR.

Blood. 2018 May 10;131(19):2120-2124. doi: 10.1182/blood-2017-12-821009. Epub 2018 Mar 5.

50.

NCCN Guidelines Insights: T-Cell Lymphomas, Version 2.2018.

Horwitz SM, Ansell SM, Ai WZ, Barnes J, Barta SK, Choi M, Clemens MW, Dogan A, Greer JP, Halwani A, Haverkos BM, Hoppe RT, Jacobsen E, Jagadeesh D, Kim YH, Lunning MA, Mehta A, Mehta-Shah N, Oki Y, Olsen EA, Pro B, Rajguru SA, Shanbhag S, Shustov A, Sokol L, Torka P, Wilcox R, William B, Zain J, Dwyer MA, Sundar H.

J Natl Compr Canc Netw. 2018 Feb;16(2):123-135. doi: 10.6004/jnccn.2018.0007.

PMID:
29439173

Supplemental Content

Loading ...
Support Center